Member Info for Fredd1eboy

This is unbelievable......Helebo has to go unless he delivers, added value, by the share consolidation date! As it stands right now I have 0% confidence in his ability to do so. Funny these days, (in a disgusting way, that is), CEO's get rewarded for failure and the foot soldiers (in this case the boffins) get paid a pittance.

Write off your shares as the muck starts hitting the fan... The auditors will probably uncover massive hospitality spend and crap financial control. I feel for the suppliers and subcontractors

Agreed MrC..I think they just expect the market...either NW and Co or us war-weary PI's to fork out once again. The writings on the wall, either expect to fork out or accept further dilution. Well, I want someone to do the honorable thing and walk away (that's you Olav)...that is unless you come up with a super duper deal that ends up justifying your existence.

Hi mbev. I enjoyed reading your post. Apart from me having a significant shareholding and you not, if I had posted myself out views would coincide. I quote ' in particular' The problem for me is that the bunch of clowns the that are running the Board are just not focused on commercialising this - this is far too much like an old government research centre. When I did hold here I did once try and contact the Board - but never got a reply - it was like they were too important to talk to me a mere shareholder ........ Keep posting and hopefully reinvest when signs of a. Reneuron pulse appear . Best wishes. Freddie

.. .Olav, why don't you compare the delivery and peripheral content of your RNS'so with Valirx.......then look at the impact on sp. Listen read and learn......you have to be more charismatic in extended content and delivery......not boring but inspiring.....listen to your scientists.....and deliver with maximum impact. Otherwise....what an earth are you doing for the company!!!!!

Hi Jack. I'd hate to think what would happen to the sp if the market wasn't taking the consolidation news very well. We are currently valued at the cash in bank figure. So all research developments over the past 10 plus years are collectively valued at zilch. Under any other circumstances one would buy, but with Olav Hellebo steering the ship close to the cliffs, no one's going to invest. We need a new CEO, one who values shareholders and share valuation. I'm 100% behind the scientists.....its the CEO I despair of.

'a rights issue' while the sp is at an all-time low......thats what not to like!

.. That's it folkes

As a long-term sufferer of Reneuron boredom, I can empathize with whoever is dumping them. Hopefully, the CEO will stand down next year and save us a few quid. Enough to employ someone akin to the PR professional who has been steering the recent Valirx fundraising initiative!

Hi Jack. Agree with you. Personally, I'm interested in CLI and licensing of the new facility....both been under the radar for a long time...fingers crossed on a good update...even better a buyout/partnership. As regards the rest...positive news all round would be appreciated....groundbreaking...albeit not expected, would be even better.

Hopefully a plus day.... http://www.lse.co.uk/share-regulatory-news.asp?shareprice=RENE&ArticleCode=u3vs63h8&ArticleHeadline=Stroke_clinical_trial_regulatory_approval_in_US

Hi DI....I'm genuinely hoping for renewed investor interest in Reneuron. Little sign to date but as you say, it can change just like that. Wish they had the same investor approach as Valirx though. It seems to be paying dividends. Best of luck. Freddie

. ..note Valirx strategy in releasing news and learn Olav!!

Hi Jack. Got to be the way forward for them. US gateway to far east and europe. In my opinion, its only a matter of time. Best wishes. Freddie

Agreed factions. Personally I'm feeling bullish. The cost of US health care is astronomical. They need inivitiave treatments and so many can afford to pay for salvaging their eyesight. The key is trials results. Watch this space. You don't open an office for no reason.

Why open an office in US....In speculating and probably through rose coloured tints but wouldnt be surprised if there's an interested party in the background. Remember the UK is a total loss at raising cash for value added intellectual property development/advancement. Im pleasantly surprised, particularly as a business update is imminent. Timing of announcement intriguing Watch this space. Best wishes. Freddie

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=RENE&ArticleCode=zqtjc36t&ArticleHeadline=ReNeuron_opens_US_office

Market going mad for small pharmas at the mo. Come on Olav and team........theres b'all interest in Rene. Get you act together

Our second application for the CTX cells is for the treatment of critical limb ischaemia. Both treatments are currently in clinical development.

A pleasure dactions. Hopefully many more positive articles to comes. As Olav says....exosomes are their gold dust....and not valued in a y of the share price forecasts!